Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
暂无分享,去创建一个
[1] T. Nielsen,et al. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). , 2003, American heart journal.
[2] P. Touboul,et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.
[3] M L Simoons,et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). , 2002, European heart journal.
[4] J. Ottervanger,et al. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. , 2002, Journal of the American College of Cardiology.
[5] William W O'Neill,et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. , 2002, Journal of the American College of Cardiology.
[6] G. Knatterud,et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. , 2002, JAMA.
[7] R. Gibbons,et al. Clinical characteristics and outcome of patients with early ( 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. , 2002 .
[8] S. Nekolla,et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial , 2002, The Lancet.
[9] G. Nichol,et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). , 2001, Journal of the American College of Cardiology.
[10] H. White,et al. One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.
[11] J. Rumsfeld,et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. , 2000, JAMA.
[12] J. Ottervanger,et al. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. , 2000, European heart journal.
[13] M. Schwaiger,et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.
[14] W. Rogers,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.
[15] H. Suryapranata,et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. , 2000, European heart journal.
[16] J. Ottervanger,et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. , 1999, The New England journal of medicine.
[17] W. Dassen,et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study , 1999, Heart.
[18] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[19] J. López-Sendón,et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. , 1999, Journal of the American College of Cardiology.
[20] J. O’Keefe,et al. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. , 1999, Journal of the American College of Cardiology.
[21] A. Vado,et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. , 1998, Journal of the American College of Cardiology.
[22] R. Gibbons,et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review , 1997 .
[23] M. Simoons,et al. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.
[24] H. Suryapranata,et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. , 1997, Journal of the American College of Cardiology.
[25] L. Grinfeld,et al. Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP): A randomized trial in a community hospital in Argentina , 1996 .
[26] A. Vado,et al. Primary angioplasty versus thrombolysis in inferior acute myocardial infarction with anterior ST-segment depression, a single-center randomized study , 1996 .
[27] S. Yusuf,et al. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. , 1995, Circulation.
[28] J. Ottervanger,et al. Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in outcome during a mean follow‐up of 18 months , 1994, Coronary artery disease.
[29] E. Ribeiro,et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. , 1993, Journal of the American College of Cardiology.
[30] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[31] K. Bailey,et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.
[32] J. Reiber,et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.
[33] B. Pitt,et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. , 1986, The New England journal of medicine.
[34] K. Karsch,et al. Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase , 1979, Clinical cardiology.
[35] M. Davies,et al. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. , 1976, British heart journal.
[36] W. Weaver,et al. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. , 2003, American heart journal.
[37] R. Collins,et al. Selection of reperfusion therapy for individual patients with evolving myocardial infarction. , 1997, European heart journal.
[38] Frans Van de Werf,et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.